83 related articles for article (PubMed ID: 19353622)
1. Central nervous system involvement in relapsed acute promyelocytic leukemia.
Kaspers G; Gibson B; Grimwade D; Pession A; Smith O; Testi AM
Pediatr Blood Cancer; 2009 Aug; 53(2):235-6; author reply 237. PubMed ID: 19353622
[No Abstract] [Full Text] [Related]
2. Prophylactic intrathecal chemotherapy in acute promyelocytic leukemia (APL).
Ravandi F
Leukemia; 2004 Apr; 18(4):879-80. PubMed ID: 14961031
[No Abstract] [Full Text] [Related]
3. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
Castagnola C; Elena C; Merli M
Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
[TBL] [Abstract][Full Text] [Related]
4. Isolated central nervous system recurrence of acute promyelocytic leukemia in children.
Chow J; Feusner J
Pediatr Blood Cancer; 2009 Jan; 52(1):11-3. PubMed ID: 18816805
[TBL] [Abstract][Full Text] [Related]
5. [Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].
Maeda A; Kobayashi Y; Saito T; Togitani K; Kawahigashi N; Tanosaki R; Takaue Y; Takenaka T; Iwata N; Tobinai K
Rinsho Ketsueki; 1999 Oct; 40(10):1081-6. PubMed ID: 10565225
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system relapse of acute promyelocytic leukemia.
Johnston DL; Mandel K
Pediatr Blood Cancer; 2010 Feb; 54(2):336-7; author reply 338. PubMed ID: 19847884
[No Abstract] [Full Text] [Related]
7. Isolated central nervous system relapse of acute promyelocytic leukemia with altered morphology in an asymptomatic patient.
Sardana R; Balakrishna JP
Blood Cells Mol Dis; 2021 Dec; 92():102616. PubMed ID: 34634584
[No Abstract] [Full Text] [Related]
8. Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Park JA; Yun JH; Kang HJ; Shin HY; Ahn HS
Pediatr Blood Cancer; 2008 Apr; 50(4):872-4. PubMed ID: 17635008
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system relapse in acute promyelocytic leukemia: a single institution experience.
Gupta V; Gonsalves W; Patnaik M; Gangat N
Leuk Lymphoma; 2013 Dec; 54(12):2728-30. PubMed ID: 23469963
[No Abstract] [Full Text] [Related]
10. [Acute promyelocytic leukemia with central nervous system leukemia--a report of two cases].
Kobayashi Y; Takahashi S; Mizuno T; Ozawa M; Horiuchi H; Maruo M; Kondo M
Gan No Rinsho; 1988 Aug; 34(9):1153-8. PubMed ID: 3172521
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system (CNS) infiltration in a case of promyelocytic leukemia.
Molero T; Valencia JM; Gómez-Casares MT
Haematologica; 1997; 82(5):637. PubMed ID: 9407740
[No Abstract] [Full Text] [Related]
12. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of relapsed acute promyelocytic leukemia in a patient receiving continuous ambulatory peritoneal dialysis with oral arsenic trioxide.
Au WY; Cheung GT; Yuen TW; Kumana CR; Kwong YL
Arch Intern Med; 2005 May; 165(9):1067-8. PubMed ID: 15883249
[No Abstract] [Full Text] [Related]
14. Central nervous system acute promyelocytic leukaemia: a report of three cases.
Marra R; Stori S; Pagano L; Fioritoni G; Rabitti C; Sica S; Leone G; Torlontano G; Bizzi B
Haematologia (Budap); 1989; 22(3):195-9. PubMed ID: 2583600
[TBL] [Abstract][Full Text] [Related]
15. Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment.
Au WY; Tam S; Kwong YL
Leuk Res; 2008 Feb; 32(2):357-8. PubMed ID: 17662385
[No Abstract] [Full Text] [Related]
16. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system relapse in acute promyelocytic leukemia.
Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
[No Abstract] [Full Text] [Related]
18. Pituitary relapse of acute promyelocytic leukemia after ATRA.
Lugassy G; Halperin Y
Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
[No Abstract] [Full Text] [Related]
19. Arsenic trioxide: new preparation. Acute promyelocytic leukaemia: encouraging results but persistent doubts.
Prescrire Int; 2004 Aug; 13(72):135-7. PubMed ID: 15532137
[TBL] [Abstract][Full Text] [Related]
20. Secondary central nervous system lymphoma: risk factors and prophylaxis.
Montoto S; Lister TA
Hematol Oncol Clin North Am; 2005 Aug; 19(4):751-63, viii. PubMed ID: 16083835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
